Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Amedisys, Inc. (AMED) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amedisys, Inc. (AMED) - free report >>
Image: Bigstock
New Strong Sell Stocks for November 8th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Alamo Group, Inc. (ALG - Free Report) designs, manufactures, and sells agricultural equipment and infrastructure maintenance equipment for governmental and industrial use. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.
Alexion Pharmaceuticals, Inc. a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The Zacks Consensus Estimate for its current year earnings has declined nearly 0.3% over the last 30 days.
Amedisys Inc. (AMED - Free Report) together with its subsidiaries, provides home health, and hospice and personal care services. It has seen the Zacks Consensus Estimate for its current year earnings being revised 10.3% downward over the last 30 days.
AptarGroup, Inc. (ATR - Free Report) provides a range of packaging, dispensing, and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The Zacks Consensus Estimate revision for its current year earnings was a negative of 2.7% over the last 30 days.
Attunity, Ltd. develops, markets, and sells big data management software solutions worldwide. The Zacks Consensus Estimate for its current year earnings has moved 134.2% lower over the last 30 days.
View the entire Zacks Rank #5 List.